Merck KGaA (OTCMKTS:MKKGY) Short Interest Up 710.0% in February

Merck KGaA (OTCMKTS:MKKGY) was the target of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 8,100 shares, an increase of 710.0% from the February 13th total of 1,000 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 238,300 shares, the days-to-cover ratio is currently 0.0 days.

Merck KGaA Stock Down 0.1 %

MKKGY stock traded down $0.04 during trading on Friday, reaching $29.11. 66,769 shares of the stock were exchanged, compared to its average volume of 124,004. The firm’s 50 day moving average is $29.28 and its 200 day moving average is $31.72. Merck KGaA has a twelve month low of $27.68 and a twelve month high of $39.17. The company has a current ratio of 1.33, a quick ratio of 0.91 and a debt-to-equity ratio of 0.28. The firm has a market cap of $18.81 billion, a P/E ratio of 17.97, a price-to-earnings-growth ratio of 2.05 and a beta of 0.98.

Merck KGaA (OTCMKTS:MKKGY) last posted its quarterly earnings results on Thursday, March 6th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.07. Merck KGaA had a return on equity of 10.41% and a net margin of 12.89%. The business had revenue of $5.78 billion for the quarter, compared to the consensus estimate of $5.40 billion. As a group, research analysts forecast that Merck KGaA will post 1.87 EPS for the current year.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.